Kye Lear
Family Medicine · Lubbock, TXNPI 1255394094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,409 and has fallen 95.5% since, to $63 in 2023.
Across 271 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$658
- AstraZeneca$432
- Pfizer$403
- Lilly USA, LLC$310
- Boehringer Ingelheim$266
- Merck$234
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,684100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $658 |
| AstraZeneca | 29 | $432 |
| Pfizer | 30 | $403 |
| Lilly USA, LLC | 28 | $310 |
| Boehringer Ingelheim | 17 | $266 |
| Merck | 18 | $234 |
| Amarin Pharma, Inc. | 10 | $138 |
| Biohaven Pharmaceuticals, Inc. | 12 | $123 |
| Bayer | 6 | $114 |
| Astellas Pharma US Inc | 6 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $109 |
| GSK | 7 | $107 |
| Esperion Therapeutics, Inc. | 6 | $106 |
| Genentech USA, Inc. | 5 | $98 |
| Avanir Pharmaceuticals, Inc. | 5 | $76 |
| Supernus Pharmaceuticals, Inc. | 2 | $64 |
| Amgen | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 4 | $50 |
| Novo Nordisk | 3 | $40 |
| Eisai Inc. | 3 | $38 |
| Tactile Systems Technology Inc | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Mylan Specialty L.p. | 1 | $26 |
| Antares Pharma, Inc. | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $15 |
| Johnson & Johnson | 1 | $12 |
| Alfasigma USA, Inc. | 1 | $12 |
How this compares
$3,684 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Lubbock
- Michael MendezLubbock$368K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.